Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-024221
Filing Date
2025-02-20
Accepted
2025-02-20 16:38:13
Documents
15
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 10-K/A engn-20241031.htm   iXBRL 10-K/A 809813
2 EX-31.3 engn-ex31_3.htm EX-31.3 13964
3 EX-31.4 engn-ex31_4.htm EX-31.4 14035
  Complete submission text file 0000950170-25-024221.txt   1261974

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT engn-20241031.xsd EX-101.SCH 74362
18 EXTRACTED XBRL INSTANCE DOCUMENT engn-20241031_htm.xml XML 19114
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 10-K/A | Act: 34 | File No.: 001-41854 | Film No.: 25646052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)